Peter Lawson
Stock Analyst at Barclays
(0)
# 4551
Out of 5,240 analysts
124
Total ratings
31.08%
Success rate
-15.47%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Biomea Fusion | Maintains: Equal-Weight | 9 11 | 4.16 | 164.42% | 4 | Oct 30, 2024 | |
Arcus Biosciences | Maintains: Overweight | 25 29 | 13.79 | 110.3% | 6 | Oct 25, 2024 | |
Revolution Medicines | Maintains: Overweight | 54 60 | 39.85 | 50.56% | 3 | Sep 27, 2024 | |
Relay Therapeutics | Maintains: Overweight | 14 17 | 4.37 | 289.02% | 5 | Sep 10, 2024 | |
Syndax Pharmaceutica... | Maintains: Overweight | 32 33 | 12.61 | 161.7% | 4 | Aug 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 5 | n/a | n/a | 4 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 92 66 | 28.5 | 131.58% | 2 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 8 | 3.04 | 163.16% | 8 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 48 | 17.2 | 179.07% | 6 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 105 | 102.53 | 2.41% | 10 | Jul 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 31 | 18.56 | 67.03% | 2 | Jul 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 17 | 10.49 | 62.06% | 3 | Jun 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 13 | 2.62 | 396.18% | 1 | May 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 9 26 | n/a | n/a | 6 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 25 25 | 35.65 | -29.87% | 4 | Apr 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 9 | 2.62 | 243.51% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 22 | 5.89 | 273.51% | 5 | Feb 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 47 63 | 32.49 | 93.91% | 3 | Feb 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 10 | 1.25 | 700% | 3 | Feb 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 27 31 | n/a | n/a | 6 | Dec 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 1 | 0.59 | 69.49% | 2 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 1.01 | 395.05% | 4 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 175 50 | 0.1 | 49900% | 2 | Aug 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 8 | 0.64 | 1150% | 2 | Aug 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 14.82 | 102.43% | 1 | Jul 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 4 | 0.85 | 311.76% | 4 | Jul 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 355 365 | 136.28 | 167.83% | 1 | Aug 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 46 | 33.33 | 38.01% | 2 | Oct 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | n/a | n/a | 1 | May 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 0.9 | 3233.33% | 1 | Mar 4, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 33 | n/a | n/a | 1 | Mar 4, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underweight | 28 | 19.15 | 46.21% | 1 | Mar 4, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 65 75 | n/a | n/a | 2 | Dec 4, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 49 | n/a | n/a | 1 | May 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | n/a | n/a | 1 | Apr 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 5 | n/a | n/a | 4 | Apr 9, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 45 | 38.34 | 17.37% | 2 | Jan 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 17 45 | 1.14 | 3847.37% | 2 | Jan 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Jan 23, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 70 | 1.05 | 6566.67% | 1 | Jul 14, 2017 |